SPEDRA

Brand name authorized in: Austria Australia Cyprus Spain Finland France Hong Kong Ireland Lithuania Netherlands New Zealand Poland United Kingdom

Active ingredients

The drug SPEDRA contains one active pharmaceutical ingredient (API):

1 Avanafil
UNII DR5S136IVO - AVANAFIL

Avanafil is a highly selective and potent, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5. When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 by avanafil produces increased levels of cGMP in the corpus cavernosum of the penis. This results in smooth muscle relaxation and inflow of blood into the penile tissues, thereby producing an erection.

Read about Avanafil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Avanafil
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE10

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 11837B, 11860F, 11861G
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 113841001, 113841002, 113841004, 113841005, 113841006, 113841008, 113841009
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 128240, 177206, 395953, 412417, 515398, 561154
FR
Base de données publique des médicaments
Identifier(s): 63294049, 66839572, 68366495
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 243961, 243963, 243967, 243968, 243972, 243973
HK
Department of Health Drug Office
Identifier(s): 65087, 65088, 65089
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1070762, 1070763, 1070764, 1070765, 1070766, 1070767, 1070768, 1070769, 1070770, 1070771, 1081293, 1091798, 1091799, 1091801, 1091802, 1091803, 1091804, 1091805, 1091806, 1091807, 1091808, 1091809
NL
Z-Index G-Standaard, PRK
Identifier(s): 115142, 115150, 115169
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 16917, 16918, 16922
PL
Rejestru Produktów Leczniczych
Identifier(s): 100307942, 100307959, 100307965